Glycine receptor, alpha 1 explained

Glycine receptor subunit alpha-1 is a protein that in humans is encoded by the GLRA1 gene.[1] [2]

Function

The inhibitory glycine receptor mediates postsynaptic inhibition in the spinal cord and other regions of the central nervous system. It is a pentameric receptor composed solely of alpha subunits. The GLRB gene encodes the alpha subunit of the receptor.[3]

Clinical significance

Mutations in the gene have been associated with hyperekplexia, a neurologic syndrome associated with an exaggerated startle reaction.[4] [5]

See also

Further reading

Notes and References

  1. Ryan SG, Sherman SL, Terry JC, Sparkes RS, Torres MC, Mackey RW . Startle disease, or hyperekplexia: response to clonazepam and assignment of the gene (STHE) to chromosome 5q by linkage analysis . Ann Neurol . 31 . 6 . 663–668 . Sep 1992 . 1355335 . 10.1002/ana.410310615 . 28879043 .
  2. Shiang R, Ryan SG, Zhu YZ, Hahn AF, O'Connell P, Wasmuth JJ . Mutations in the alpha 1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia . Nat Genet . 5 . 4 . 351–358 . Mar 1994 . 8298642 . 10.1038/ng1293-351 . 21410824 .
  3. Web site: Entrez Gene: GLRA1 glycine receptor, alpha 1 (startle disease/hyperekplexia, stiff man syndrome).
  4. Tijssen MA, Shiang R, van Deutekom J, Boerman RH, Wasmuth JJ, Sandkuijl LA, Frants RR, Padberg GW . Molecular genetic reevaluation of the Dutch hyperekplexia family . Arch. Neurol. . 52 . 6 . 578–582 . June 1995 . 7763205 . 10.1001/archneur.1995.00540300052012 . 2066/20657 . 14067463 . free .
  5. Zhou L, Chillag KL, Nigro MA . Hyperekplexia: a treatable neurogenetic disease . Brain Dev. . 24 . 7 . 669–674 . October 2002 . 12427512 . 10.1016/S0387-7604(02)00095-5 . 40864297 .